Physician profile
Adam Levin
NPI 1851613418
$11,077.47
in general payments reported to CMS, 2019-2025
6 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $100 · 2024: $290 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,935 · Travel and Lodging: $1,676 · Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,935.00 |
| Travel and Lodging | $1,675.66 |
| Food and Beverage | $366.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $6,648.11 | 2022-2025 | Turalio |
| Restor3d, INC. | $4,097.40 | 2025 | |
| Zimmer Biomet Holdings, INC. | $139.40 | 2024 | Persona |
| Encore Medical, LP | $127.59 | 2024 | Djo Surgical |
| Janssen Biotech, INC. | $42.39 | 2025 | Tremfya |
| Smith+Nephew, INC. | $22.58 | 2024 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.